These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19479974)

  • 1. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of early-stage mucinous gastric carcinoma.
    Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
    Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics and prognosis of mucinous gastric carcinoma.
    Zhang M; Zhu GY; Zhang HF; Gao HY; Han XF; Xue YW
    J Surg Oncol; 2010 Jul; 102(1):64-7. PubMed ID: 20578080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathology and prognosis of mucinous gastric carcinoma.
    Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics of mucinous gastric adenocarcinoma.
    Hyung WJ; Noh SH; Shin DW; Yoo CH; Kim CB; Min JS; Lee KS
    Yonsei Med J; 1999 Apr; 40(2):99-106. PubMed ID: 10333711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor size predicts survival in mucinous gastric carcinoma.
    Sung CO; Lee SM; Choi JS; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim WH; Park CK; Kim S
    J Surg Oncol; 2012 Nov; 106(6):757-64. PubMed ID: 22535583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
    Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
    Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
    Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
    J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
    Choi JS; Seo J; Jung EJ; Kim EJ; Lee GK; Kim WH
    Anticancer Res; 2012 Nov; 32(11):5031-7. PubMed ID: 23155275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
    Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
    J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach.
    Kim MA; Lee HS; Yang HK; Kim WH
    Cancer; 2005 Apr; 103(7):1439-46. PubMed ID: 15726543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases.
    Roh JH; Srivastava A; Lauwers GY; An J; Jang KT; Park CK; Sohn TS; Kim S; Kim KM
    Am J Surg Pathol; 2010 Aug; 34(8):1139-46. PubMed ID: 20661012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
    Gürbüz Y; Kahlke V; Klöppel G
    Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
    Sasaki I; Yao T; Nawata H; Tsuneyoshi M
    Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.